Koen van de Wetering
Koen van de Wetering
確認したメール アドレス: jefferson.edu
タイトル
引用先
引用先
Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer
S Rottenberg, AOH Nygren, M Pajic, FWB van Leeuwen, ...
Proceedings of the National Academy of Sciences 104 (29), 12117-12122, 2007
3272007
Multidrug resistance-associated proteins 3, 4, and 5
P Borst, C de Wolf, K van de Wetering
Pflügers Archiv-European Journal of Physiology 453 (5), 661-673, 2007
3222007
Collectins
JK van de Wetering, LMG van Golde, JJ Batenburg
European Journal of Biochemistry 271 (7), 1229-1249, 2004
2752004
Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception
N Zelcer, K van de Wetering, M Hillebrand, E Sarton, A Kuil, PR Wielinga, ...
Proceedings of the National Academy of Sciences 102 (20), 7274-7279, 2005
2102005
ABCC6–mediated ATP secretion by the liver is the main source of the mineralization inhibitor inorganic pyrophosphate in the systemic circulation—Brief report
RS Jansen, S Duijst, S Mahakena, D Sommer, F Szeri, A Váradi, A Plomp, ...
Arteriosclerosis, thrombosis, and vascular biology 34 (9), 1985-1989, 2014
1942014
Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronides
N Zelcer, K van de Wetering, R de Waart, GL Scheffer, HU Marschall, ...
Journal of hepatology 44 (4), 768-775, 2006
1912006
ABCC6 prevents ectopic mineralization seen in pseudoxanthoma elasticum by inducing cellular nucleotide release
RS Jansen, A Küçükosmanoğlu, M De Haas, S Sapthu, JA Otero, ...
Proceedings of the National Academy of Sciences 110 (50), 20206-20211, 2013
1732013
Intestinal breast cancer resistance protein (BCRP)/Bcrp1 and multidrug resistance protein 3 (MRP3)/Mrp3 are involved in the pharmacokinetics of resveratrol
K van de Wetering, A Burkon, W Feddema, A Bot, H de Jonge, V Somoza, ...
Molecular pharmacology 75 (4), 876-885, 2009
1452009
Identification of multidrug resistance protein 1 (MRP1/ABCC1) as a molecular gate for cellular export of cobalamin
R Beedholm-Ebsen, K van de Wetering, T Hardlei, E Nexø, P Borst, ...
Blood, The Journal of the American Society of Hematology 115 (8), 1632-1639, 2010
1362010
Functionally overlapping roles of Abcg2 (Bcrp1) and Abcc2 (Mrp2) in the elimination of methotrexate and its main toxic metabolite 7-hydroxymethotrexate in vivo
MLH Vlaming, Z Pala, A van Esch, E Wagenaar, DR de Waart, ...
Clinical Cancer Research 15 (9), 3084-3093, 2009
1132009
Multidrug resistance proteins 2 and 3 provide alternative routes for hepatic excretion of morphine-glucuronides
K van de Wetering, N Zelcer, A Kuil, W Feddema, M Hillebrand, ...
Molecular pharmacology 72 (2), 387-394, 2007
1102007
Characteristics of surfactant protein A and D binding to lipoteichoic acid and peptidoglycan, 2 major cell wall components of gram-positive bacteria
J de Wetering, M Van Eijk, LMG Van Golde, T Hartung, JAG Van Strijp, ...
Journal of Infectious Diseases 184 (9), 1143, 2001
902001
On the putative co-transport of drugs by multidrug resistance proteins
P Borst, N Zelcer, K Van de Wetering, B Poolman
FEBS letters 580 (4), 1085-1093, 2006
862006
Does the absence of ABCC6 (multidrug resistance protein 6) in patients with Pseudoxanthoma elasticum prevent the liver from providing sufficient vitamin K to the periphery?
P Borst, K van de Wetering, R Schlingemann
Cell Cycle 7 (11), 1575-1579, 2008
782008
Abcc2 (Mrp2), Abcc3 (Mrp3), and Abcg2 (Bcrp1) are the main determinants for rapid elimination of methotrexate and its toxic metabolite 7-hydroxymethotrexate in vivo
MLH Vlaming, A van Esch, Z Pala, E Wagenaar, K van de Wetering, ...
Molecular cancer therapeutics 8 (12), 3350-3359, 2009
752009
Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides
C De Wolf, R Jansen, H Yamaguchi, M De Haas, K Van De Wetering, ...
Molecular cancer therapeutics 7 (9), 3092-3102, 2008
742008
Impact of Abcc2 (Mrp2) and Abcc3 (Mrp3) on the in vivo elimination of methotrexate and its main toxic metabolite 7-hydroxymethotrexate
MLH Vlaming, Z Pala, A van Esch, E Wagenaar, O van Tellingen, ...
Clinical Cancer Research 14 (24), 8152-8160, 2008
682008
Transportomics: screening for substrates of ABC transporters in body fluids using vesicular transport assays
P Krumpochova, S Sapthu, JF Brouwers, M de Haas, R de Vos, P Borst, ...
The FASEB Journal 26 (2), 738-747, 2012
652012
Transport of diclofenac by breast cancer resistance protein (ABCG2) and stimulation of multidrug resistance protein 2 (ABCC2)-mediated drug transport by diclofenac and …
JS Lagas, CMM van der Kruijssen, K van de Wetering, JH Beijnen, ...
Drug Metabolism and Disposition 37 (1), 129-136, 2009
622009
Targeted metabolomics identifies glucuronides of dietary phytoestrogens as a major class of MRP3 substrates in vivo
K Van De Wetering, W Feddema, JB Helms, JF Brouwers, P Borst
Gastroenterology 137 (5), 1725-1735, 2009
612009
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20